newsfilter
← Latest News
GlobeNewswire·

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

BEDFORD, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation